Europe Enteral Feeding Formula Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 6.47 Billion |
 Market Size (Forecast Year) |
USD 9.64 Billion |
 CAGR |
% |
| Major Markets Players |
|
Europe Enteral Feeding Formula Market, By Product (Standard Formulas and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Others) Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding, and Duodenal or Jejunal Tube Feeding), Stage (Adult and Paediatric), End-User (Hospitals and Long Term Care Facilities) – Industry Trends and Forecast to 2030.
Europe Enteral Feeding Formula Market Analysis and Size
The rise in the prevalence of rheumatoid arthritis and asthma worldwide, increasing geriatric population, growing government initiatives, heightening number of the obese population, advancement in treatment options, and rising awareness are the factors that will expand the Europe enteral feeding formula market. The development of vegetarian enteral feeding formula is critical when many individuals are converting to a vegan diet to live a healthier lifestyle as it’s a vegetarian-friendly formula, vegetarian enteral feeding formula is one of the safest vegetarian joint supplements. Moreover, rising R&D activities, ongoing clinical trials, and emerging markets will create new opportunities for the Europe enteral feeding formula market in the forecast period.
Data Bridge Market Research analyses that the Europe enteral feeding formula market which was USD 6.47 billion in 2022, and would rocket up to USD 9.64 billion by 2030, and is expected to undergo a CAGR of 5.2% during the forecast period. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Europe Enteral Feeding Formula Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
By Product (Standard Formulas and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Others) Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding, and Duodenal or Jejunal Tube Feeding), Stage (Adult and Paediatric), End-User (Hospitals and Long Term Care Facilities) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Nutricia (Netherlands), Hormel Foods Corporation (U.S), Medline Industries, Inc. (U.S), Mead, Johnson & Company, LLC. (U.S), Nestlé Health Science (Switzerland), Abbott (U.S), Meiji Holdings Co., Ltd. (Japan), Fresenius Kabi AG (Germany), B. Braun Melsungen AG (Germany), EuropeHealth Product Inc. (U.S), Trovita Health Science (U.S), Victus Inc. (U.S), Avanos Medical Inc. (U.S), Cardinal Health (U.S), Moog Inc (U.S), Conmed Corporation (U.S), Cook Medical (Indiana), among others |
|
Market Opportunities |
|
Market Definition
Enteral tube feeding is the introduction of nutrients by tubes into the gut or stomach for individuals who are unable to satisfy their nutritional needs or who are unable to absorb oral nutrients. Tubes such as the nasojejunal tube, gastrostomy, nasogastric tube, and jejunostomy are available for enteral feed formula. The many ways utilized to deliver the required nutrients are cost-effective, nutritious, and a viable alternative to the invasive procedure.
Europe Enteral Feeding Formula Market Dynamics
Drivers
- Rising cases of chronic diseases across the globe
The primary drivers that have fuelled the market demand in the projection period are technological advancements in enteral feeding formula. For patients with surgical damage, lactose tolerance, burns, ulcers, and other problems, the formula, which is rooted in the body, mainly consists of different minerals and proteins such as fibres, vitamins, proteins, and others. With more preterm deliveries and the development of more technologically advanced enteral feeding formula, demand for enteral feeding formula has increased compared to the previous year. In addition, demand for enteral feeding formula has surged as people worldwide become more health concerned.
- Rise in the geriatric population
Europe is witnessing a steady increase in the geriatric population, which has resulted in an increase in chronic diseases in the region. The EU-27's growing geriatric population (those aged 85 and up) has several consequences. The expense of providing proper health and long-term care is one of the primary areas of worry for the concerned authority, as extremely old people tend to require proportionally more social services. Furthermore, the senior population, which is affected by neurological disorders such as multiple sclerosis, stroke, and dementia that inhibit swallowing, is the largest target audience for this market.
- Expansion in product portfolio
Major market players' development of product portfolios is credited with driving growth in the Europe market for enteral feeding formulae. Leading pharmaceutical and nutraceutical firms invest heavily in research and development (R & R&D), resulting in product breakthroughs moving the market forward. The advent of ready-to-drink (RTD) products, ready-to-use nutritional supplements, and improvements in tube quality are all contributing to the market's growth.
Opportunity
- New product launches in the enteral feeding devices
In Europe, the enteral feeding devices market has seen new product introductions in recent years, and these unique product innovations are proving to be a part of the enteral feeding devices market's tremendous potential opportunities. Furthermore, technical advances and product innovations are some of the major factors driving the growth of the enteral feeding formula market. The market's growth is being aided by key players' diverse product portfolios and robust product developments. Some of the product categories that have gained traction in recent years include ready-to-drink (RTD), ready-to-use nutritional supplements, tube feed, and tube feed for certain specialized purposes.
Restraint/Challenge
- Complications associated with enteral feeding devices
According to the National Center for Biotechnology Information of the U.S. National Library of Medicine, gastrostomy and/or jejunostomy feeding tubes are routinely implanted and used for long-term home enteral nutrition support. Although the insertion of these tubes is usually associated with modest morbidity, their long-term usage can lead to various difficulties and disorders that can impair quality of life and have considerable financial implications. These issues contribute to the region's limited growth in the Europe enteral feeding devices market.
This Europe enteral feeding formula market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the enteral feeding formula market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Development
- In December 2021, Nestlé Health Science created a website in collaboration with healthcare professionals to offer information and support at every phase of the disease. The company emphasized the value of nutrition as part of a new initiative to inform and support cancer patients and their caregivers
Europe Enteral Feeding Formula Market Scope
The Europe enteral feeding formula market is segmented on the basis of product, stage, type of tube feeding, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Standard formula
- Disease-specific formula
Stage
- Adult
- Paediatric
Type of Tube Feeding
- Gastric Tube Feeding
- Nasogastric Tube Feeding
- Gastrostomy Tube Feeding
- Duodenal or Jejunal Tube Feeding
End-user
- Hospitals
- Cardiology
- Neurology
- Critical Care (ICU)
- Oncology
- Others
- Home Care
Application
- Oncology
- Neurology
- Critical Care
- Diabetes,
- Gastroenterology
- others
Europe Enteral Feeding Formula Market Regional Analysis/Insights
The enteral feeding formula market is analyzed, and market size insights and trends are provided by country, product, stage, type of tube feeding, indication, and end-user.
The countries covered in the enteral feeding formula market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
Germany is expected to dominate the enteral feeding formula market due to the presence of major key players, continuous technological development and increasing awareness towards health in this region.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Europe enteral feeding formula market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for enteral feeding formula market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the enteral feeding formula market. The data is available for historic period 2015-2021.
Competitive Landscape and Enteral Feeding Formula Market Share Analysis
The Europe enteral feeding formula market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Europe enteral feeding formula market.
Some of the major players operating in the Europe enteral feeding formula market are:
- Nutricia (Netherlands)
- Hormel Foods Corporation (U.S)
- Medline Industries, Inc. (U.S)
- Mead Johnson & Company, LLC. (U.S)
- Nestlé Health Science (Switzerland)
- Abbott (U.S)
- Meiji Holdings Co., Ltd. (Japan)
- Fresenius Kabi AG (Germany)
- B. Braun Melsungen AG (Germany)
- EuropeHealth Product Inc. (U.S)
- Trovita Health Science (U.S)
- Victus Inc. (U.S)
- Avanos Medical Inc. (U.S)
- Cardinal Health (U.S)
- Moog Inc (U.S)
- Conmed Corporation (U.S)
- Cook Medical (Indiana)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
